Earnings History Data for Kiniksa Pharmaceuticals (KNSA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-02-2024 PM KNSA Kiniksa Pharmaceuticals 1,407 0.04 -0.11 0.00 Kiniksa Pharmaceuticals GAAP EPS of $0.35 beats by $0.49, revenue of $83.4M beats by $11.13M
[2/28/2024 7:31 AM]
20.28 -0.61 
(-2.92%)
21.70 0.81 
(3.88%)
10.29 - 21.98 435,088 290,000 5,714
31-10-2023 PM KNSA Kiniksa Pharmaceuticals, Ltd. 1,060 -0.20 -0.18 0.67 Kiniksa Pharmaceuticals GAAP EPS of -$0.20 misses by $0.03, revenue of $67.05M beats by $2.6M
[10/31/2023 7:44 AM]
15.25 -0.43 
(-2.74%)
14.95 -0.73 
(-4.66%)
10.29 - 20.65 728,569 340,000 13,751
25-07-2023 PM KNSA Kiniksa Pharmaceuticals, Ltd. 2,180 -0.02 -0.16 -0.29 Kiniksa Pharmaceuticals GAAP EPS of $0.21 beats by $0.38, revenue of $71.47M beats by $19.27M
[7/25/2023 7:36 AM]
19.47 4.53 
(30.32%)
16.98 2.04 
(13.65%)
9.63 - 20.00 4,315,740 480,000 21,653
01-11-2022 PM 7:30 AM ET
(Nov 1)
KNSA Kiniksa Pharmaceuticals 814.00 0.67 0.38 0.00 Kiniksa Pharmaceuticals GAAP EPS of $3.18, revenue of $99.13M
[11/1/2022 8:44 AM]
12.87 1.45 
(12.70%)
11.74 0.32 
(2.80%)
7.36 - 15.24 1,134,394 260,000 742
03-08-2022 PM 8:00 AM ET
(Aug 3)
KNSA Kiniksa Pharmaceuticals, Ltd. 760.65 -0.29 -0.43 -0.61 Kiniksa Pharmaceuticals GAAP EPS of -$0.29 beats by $0.15, revenue of $26.97M misses by $1.58M, reaffirms FY revenue guidance
[8/3/2022 8:09 AM]
10.66 0.69 
(6.92%)
10.45 0.48 
(4.81%)
7.36 - 15.92 1,956,203 200,000 75,026
01-11-2021 PM 8:00 AM ET
(Nov 1)
KNSA Kiniksa Pharmaceuticals 750.00 -0.44 -0.63 0.00 Kiniksa Pharmaceuticals EPS beats by $0.19, beats on revenue
[11/1/2021 8:05 AM]
12.72 2.33 
(22.43%)
10.90 0.51 
(4.91%)
10.30 - 24.70 1,095,361 230,000 3,327
03-08-2021 PM 8:00 AM ET
(Aug 3)
KNSA Kiniksa Pharmaceuticals, Ltd. 1,050 -0.61 -0.69 -0.65 Kiniksa Pharmaceuticals EPS misses by $0.66, beats on revenue
[8/3/2021 8:22 AM]
13.51 -2.72 
(-16.79%)
15.85 -0.38 
(-2.34%)
12.63 - 24.70 2,518,562 540,000 24,498
04-05-2021 PM KNSA Kiniksa Pharmaceuticals, Ltd. 1,150 -0.72 -0.73 -0.48 Kiniksa Pharmaceuticals EPS misses by $0.08
[5/4/2021 8:13 AM]
15.78 -0.74 
(-4.48%)
15.78 0.0 
(0.00%)
14.51 - 28.67 292,301 290,000 23,031
23-02-2021 PM KNSA Kiniksa Pharmaceuticals, Ltd. 1,590 -0.79 -0.61 -0.58 Kiniksa Pharmaceuticals EPS misses by $0.18
[2/23/2021 8:08 AM]
20.85 -1.02 
(-4.66%)
21.90 0.03 
(0.14%)
10.30 - 28.67 256,718 392,776 140